ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)

About the company

ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

338

$203.00M

Total Revenue

338

Employees

$370.68M

Market Capitalization

-237.62

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$133M

Operating Margin (in %)

Total operating margin

$4M

Net Margin (in %)

Total net margin

$-1M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12203.10 1376.00 5.20 19.24 43.06
Catalent, Inc. CTLT 10838.26 2872.00 5.44 103.91 3.63
Perrigo Co. Plc PRGO 7571.99 4837.00 1.30 51.65 3.02
Bausch Health Cos., Inc. BHC 6707.00 8597.00 9.36 -3.54 -21.96
Jazz Pharmaceuticals Plc JAZZ 6338.40 2188.00 2.19 23.17 12.81
United Therapeutics Corp. UTHR 5118.72 1443.00 1.78 9.88 36.59
MyoKardia, Inc. MYOK 4243.04 34.00 12.33 -13.69 -201.73
Axsome Therapeutics, Inc. AXSM 2833.95 None 19.23 -31.51 None
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Pacira Biosciences, Inc. PCRX 2199.54 435.00 5.90 -5237.00 -0.02
SAGE Therapeutics, Inc. SAGE 2181.92 9.00 2.56 -3.37 -413.06
Corcept Therapeutics, Inc. CORT 2039.84 335.00 4.68 19.22 31.64
Prestige Consumer Healthcare, Inc. PBH 1850.28 963.00 1.56 13.05 14.77
Revolution Medicines, Inc. RVMD 1738.14 48.00 4.51 -24.55 -146.29
Madrigal Pharmaceuticals, Inc. MDGL 1673.70 0.00 4.47 -16.38 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1598.26 440.00 -22.62 18.85 19.14
Innoviva, Inc. INVA 1580.87 285.00 3.74 8.18 66.41
Intercept Pharmaceuticals, Inc. ICPT 1475.20 272.00 -43.90 -4.30 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Zogenix, Inc. ZGNX 1313.55 5.00 3.59 -3.09 -241.62
Supernus Pharmaceuticals, Inc. SUPN 1274.94 402.00 2.02 10.93 28.90
Revance Therapeutics, Inc. RVNC 1230.46 0.00 4.86 -6.59 41.82
Theravance Biopharma, Inc. TBPH 1169.64 88.00 -8.21 -4.74 -280.80
Amphastar Pharmaceuticals, Inc. AMPH 1074.08 327.00 2.68 21.08 15.90
Endo International Plc ENDP 824.22 3014.00 -1.13 -2.94 -9.09
BellRing Brands, Inc. BRBR 771.22 954.00 -0.42 5.85 13.98
Eagle Pharmaceuticals, Inc. EGRX 671.16 192.00 3.61 266.33 1.29
Assembly Biosciences, Inc. ASMB 669.03 16.00 3.00 -6.73 -601.75
Aerie Pharmaceuticals, Inc. AERI 641.70 79.00 5.09 -3.17 -252.92
Collegium Pharmaceutical, Inc. COLL 593.64 299.00 4.25 -45.95 -4.21
Anika Therapeutics, Inc. ANIK 533.82 125.00 1.84 19.26 22.73
Catalyst Pharmaceuticals, Inc. CPRX 524.30 119.00 5.10 11.95 36.09
Intersect ENT, Inc. XENT 439.36 102.00 4.15 -8.80 -48.61
BioDelivery Sciences International, Inc. BDSI 408.48 130.00 5.84 -55.50 -5.01
ANI Pharmaceuticals, Inc. ANIP 370.68 203.00 1.90 -237.62 -0.67
Albireo Pharma, Inc. ALBO 342.42 11.00 3.48 -4.48 -730.55
MEI Pharma, Inc. MEIP 283.86 5.00 4.89 -7.28 -539.48
Mallinckrodt Plc MNK 209.16 3037.00 0.11 -0.17 -39.56
Agile Therapeutics, Inc. AGRX 163.43 None 2.66 -7.91 None
Marinus Pharmaceuticals, Inc. MRNS 161.60 0.00 6.26 -2.40 None
Cerecor, Inc. CERC 118.22 7.00 7.56 -5.24 -429.22
Ampio Pharmaceuticals, Inc. AMPE 98.67 1.00 69.00 -5.31 None
Evoke Pharma, Inc. EVOK 89.28 None 31.00 -13.29 None
AcelRx Pharmaceuticals, Inc. ACRX 84.80 2.00 -1.56 -1.51 -644.25
Zynerba Pharmaceuticals, Inc. ZYNE 80.50 0.00 1.32 -2.24 -699.94
Adamas Pharmaceuticals, Inc. ADMS 71.68 57.00 -4.57 -0.77 -160.44
CTI BioPharma Corp. CTIC 69.62 3.00 3.11 -1.69 -111.83
Aclaris Therapeutics, Inc. ACRS 68.88 4.00 1.21 -0.50 None
Oramed Pharmaceuticals, Inc. ORMP 63.90 3.00 5.14 -5.00 -464.15
Cassava Sciences, Inc. SAVA 56.43 41.00 2.97 -12.38 76.71
Natural Alternatives International, Inc. NAII 49.77 114.00 0.68 -13.17 -3.19
SCYNEXIS, Inc. SCYX 48.89 0.00 10.27 -1.26 -30.84
Cumberland Pharmaceuticals, Inc. CPIX 48.60 47.00 0.99 -10.80 -9.59
Lipocine, Inc. LPCN 43.50 0.00 10.36 -2.90 None
IsoRay, Inc. ISR 38.19 9.00 7.12 -11.40 -36.08
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 35.45 65.00 -2.73 -2.03 -26.74
PLx Pharma, Inc. PLXP 27.18 0.00 -2.60 -2.88 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 19.24 3.00 2.39 -1.62 -264.21
Regulus Therapeutics, Inc. RGLS 14.49 0.00 1.28 -0.68 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.30 8.00 0.65 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.43 None 1.34 -0.24 None
VIVUS, Inc. VVUS 8.69 73.00 -0.19 -0.29 -39.28
Sonoma Pharmaceuticals, Inc. SNOA 6.46 19.00 1.02 -2.07 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Hepion Pharmaceuticals, Inc. HEPA 5.68 None 1.77 -0.48 None
Tonix Pharmaceuticals Holding Corp. TNXP 4.20 None 1.05 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Hedge Funds Are Selling ANI Pharmaceuticals Inc (ANIP)

2d ago, source: YAHOO!

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive ...

ANI Pharmaceuticals Announces Acquisition of Fluconazole Tablets

17h ago, source: Business Insider

PRNewswire/ -- ANI Pharmaceuticals, Inc. ('ANI') (Nasdaq: ANIP) today announced the acquisition of Fluconazole ...

ANI Pharmaceuticals: Significantly Undervalued

Opinion ago, source: Seeking Alpha

ANI Pharmaceuticals, Inc. (ANIP) has seen its shares crater over 60% in the past ten months with disappointing results and ...

ANI Pharma Acquires Fluconazole Tablets For $3.0 Mln

17h ago, source: Business Insider

(RTTNews) - ANI Pharmaceuticals Inc. (ANIP) said that it has acquired Fluconazole Tablets USP, 50mg, 100mg, 150mg, and 200mg from a private ...

ANI Pharma To Launch Mexiletine Hydrochloride Capsules - Quick Facts

6d ago, source: Nasdaq

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) announced the launch of Mexiletine Hydrochloride Capsules USP, 150mg, 200mg and ...

ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules

6d ago, source: MarketWatch

("ANI") (Nasdaq:ANIP) today announced the launch of Mexiletine Hydrochloride Capsules USP, 150mg, 200mg and 250mg. The current annual U.S. market for this product is approximately $16 million, ...

Edge Pharma Completes Supplier Agreement with ANI Pharmaceuticals, Inc

11d ago, source: Benzinga.com

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its targeted areas of product ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.